Pancreatic cancer detection

Show results for

Unknown (1273)
Transcriptomics (529)
Genomics (147)
Proteomics (68)
Clinical (25)
Metabolomics (15)
Other (5)
Methylation profiling (3)

Organisms

Homo sapiens (469)
Mus musculus (144)
Saccharomyces cerevisiae (7)
Rattus norvegicus (6)
Pseudomonas aeruginosa (4)
Oncorhynchus mykiss (3)
Sus scrofa (3)
Danio rerio (3)
Thermus thermophilus HB8 (2)
Macaca mulatta (2)
mouse gut metagenome (2)
Zea mays (2)
Mayaro virus (1)
Synechococcus sp. WH 7803 (1)
Vitis sp. cv. 'Norton' (1)
environmental samples (1)
Brucella melitensis bv. 1 str. 16M (1)
Bradyrhizobium japonicum (1)
Bacillus anthracis str. Sterne (1)
Leishmania major (1)
Fragaria x ananassa (1)
Halobacterium salinarum (1)
Xylella fastidiosa (1)
Apis mellifera (1)
Oryza sativa (1)
Bacillus subtilis (1)
Staphylococcus aureus (1)
Oryza sativa Japonica Group (1)
Caenorhabditis elegans (1)
Gallus gallus (1)

Organisms

Homo sapiens (46)
Mus musculus (13)
human saliva metagenome (1)

Repository

biostudies-arrayexpress (532)
ENA (82)
pride (50)
geo (43)
EGA (31)
MetaboLights (13)
MassIVE (8)
iProX (4)
jPOST (2)
ExpressionAtlas (1)
EVA (1)
GNPS (1)
NODE (1)

Tissue

Cell culture (11)
Blood serum (9)
Pancreas (8)
Blood plasma (7)
Epithelial cell (4)
Blood (2)
Macrophage (2)
Pancreatic cancer cell line (2)
Pancreatic ductal adenocarcinoma cell (2)
Pancreatic ductal adenocarcinoma cell line (2)
Pancreatic ductal cell (2)
Adenocarcinoma cell line (1)
Bile (1)
Bile duct (1)
Blood-lymph (1)
Bone marrow (1)
Brain (1)
Carcinoma cell (1)
Cell line cell (1)
Colon (1)
Epithelial cell of exocrine pancreas (1)
Epithelium of pancreatic duct (1)
Fibroblast (1)
Islet of Langerhans (1)
Kidney (1)
Liver (1)
Lung (1)
Lung cancer cell line (1)
PanIN cell (1)
SW-1990 cell (1)

Disease

Pancreatic cancer (12)
Normal (3)
Neoplasms (3)
Breast adenocarcinoma (2)
Breast cancer (2)
Pancreatic ductal carcinoma (2)
Lung Neoplasms (2)
Healthy (1)
Hepatocellular carcinoma-non tumorous region (1)
Neuroepithelioma (1)
Colon mucinous adenocarcinoma (NCI Metathesaurus CL029553) in DiseaseLocation rectosigmoid colon has DiseaseStaging T3N2M1 (1)
Liposarcoma (1)
Familial adenomatous polyposis (FAP) (1)
Normal (1)
Prostate cancer (1)
Breast carcinoma (1)
Central nervous system cancer (1)
Tuberculosis (1)
Thromboembolism (1)
Malignant neoplasm of pancreas (1)
Esophageal cancer, Gastric cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Biliary cancer, disease in GI tract (1)
Patients suffering from tumors such as colorectal, lung and pancreatic cancer and precancerous disease (1)
Pancreatic cancer Colon cancer Hepatocellar carcinoma Gastric cancer Bile duct cancer Inflammatory bowel disease (Ulcerative colitis, Crohn) Intraductal papillary mucinous neoplasm Autoimmune disease Hepatic/ digestive tract disorder (1)
Colorectal cancer, Gastric cancer, Hepatobiliary pancreatic diseases (1)
Colorectal Cancer (CRC) and Pancreatic Cancer (PaCa) (1)
Peutz-Jeghers Syndrome (1)
Esophageal carcinoma (1)
Adrenal Cortex Neoplasms (1)
Liver Neoplasms (1)
Melanoma (1)

Technology Type

Mass Spectrometry (50)
Shotgun proteomics (18)
Bottom-up proteomics (16)
Mass spectrometry (8)
Data-independent acquisition (7)
Mass spectrometry assay (5)
Data-dependent acquisition (5)
SWATH MS (5)
SRM/MRM (3)
Top-down proteomics (3)
Illumina MiSeq (1)
Affinity purification coupled with mass spectrometry proteomics (1)
All-ion fragmentation (1)
DiaPASEF (1)
Immunopeptidomics (1)

Instrument Platform

Illumina NovaSeq 6000 (11)
NextSeq 550 (3)
Illumina HiSeq 2500 (3)
Affymetrix GeneChip Scanner 3000 (GCS3000) (2)
GenePix 4000B [Axon Instruments] (2)
Affymetrix Fluidics Station 400 (2)
Illumina NovaSeq X (2)
Agilent Bioanalyzer 2100 (or TapeStation); Qubit 4 Fluorometer (Thermo Fisher Scientific) (1)
NanoDrop ND-1000 spectrophotometer (1)
Whole Transcriptome v2 kit (1)
Illumina-compatible library preparation equipment (1)
Monarch RNA purification column system (1)
Standard mammalian cell culture equipment (1)
Linux server (GPU/CPU cluster) (1)
Biological safety cabinet, centrifuge, 40 µm strainer (1)
Standard cell culture setup (1)
Cell culture incubator (37 °C, 5 % CO₂) (1)
Agilent DNA Microarray Scanner Model #G2565BA (1)
Affymetrix GeneArray Scanner (1)
Agfa 1236s (1)
Typhoon TRIO (1)
GenePix 4000A [Axon Instruments] (1)
G2565AA DNA microarray scanner [Agilent] (1)
Axon- GenePix4000B (1)
ScanArray Express HT [PerkinElmer] (1)
NextSeq 2000 (1)
DNBSEQ-T7 (1)
BGISEQ-500 (1)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)

Publication Date

2013 (94)
2012 (70)
2010 (69)
2014 (68)
2011 (58)
2015 (55)
2016 (40)
2026 (33)
2025 (28)
2008 (28)
2009 (19)
2024 (17)
2022 (15)
2023 (13)
2020 (12)
2021 (11)
2007 (6)
2017 (5)
2005 (5)
2019 (4)
2018 (2)
2006 (1)

CHEBI ID

CHEBI:17368 (7)
CHEBI:17596 (6)
CHEBI:16750 (6)
CHEBI:16737 (6)
CHEBI:16393 (5)
CHEBI:17202 (5)
CHEBI:16919 (5)
CHEBI:16566 (5)
CHEBI:17015 (5)
CHEBI:16828 (5)
CHEBI:17895 (5)
CHEBI:17295 (5)
CHEBI:15971 (5)
CHEBI:32797 (5)
CHEBI:16015 (5)
CHEBI:17203 (5)
CHEBI:30887 (5)
CHEBI:16704 (5)
CHEBI:78679 (4)
CHEBI:15978 (4)
CHEBI:17620 (4)
CHEBI:30763 (4)
CHEBI:17405 (4)
CHEBI:16410 (4)
CHEBI:17552 (4)
CHEBI:17239 (4)
CHEBI:16027 (4)
CHEBI:28053 (4)
CHEBI:16695 (4)
CHEBI:15727 (4)

Metabolite Name

Hypoxanthine (4)
Malonic acid (3)
Creatine (3)
Creatinine (3)
L-Tryptophan (3)
L-Tyrosine (3)
L-Phenylalanine (3)
L-Histidine (3)
L-Proline (3)
Uracil (3)
Xanthine (3)
L-2-hydroxyglutaric acid (2)
DATP (2)
D-xylose (2)
L-Homocystine (2)
2,6-diaminopimelic acid (2)
Aminomethylphosphonic acid (2)
Hydrocinnamic acid (2)
Succinic semialdehyde (2)
Deoxycholic acid (2)
Cholic acid (2)
Isopentenyl pyrophosphate (2)
L-Cystathionine (2)
Isovaleric acid (2)
L-Cystine (2)
GTP (2)
GDP (2)
ATP (2)
L-carnitine (2)
Butanoic acid (2)

First Public Date

2025 (17)
2026 (13)
2024 (10)
2020 (8)
2023 (7)
2014 (7)
2022 (6)
2021 (6)
2019 (5)
2017 (1)
2016 (1)
2015 (1)

Modification

2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)

Study status

Recruiting (15)
Completed (4)
Not provided (2)
Enrolling by invitation (1)
Withdrawn (1)
Terminated (1)
Not yet recruiting (1)

Study type

Transcription profiling by array (377)
Methylation profiling by array (26)
RNA-seq of coding RNA (18)
Comparative genomic hybridization by array (16)
Observational (16)
Unknown experiment type (14)
ChIP-seq (14)
Transcription profiling by RT-PCR (13)
Other (12)
Interventional (7)
ChIP-chip by array (6)
RNA-seq of coding RNA from single cells (6)
MicroRNA profiling by array (5)
DNA-seq (5)
ChIP-chip by tiling array (3)
Proteomic profiling by array (3)
RNA-seq of non coding RNA (3)
Methylation profiling by high throughput sequencing (2)
RNA-seq of total RNA (2)
Observational patient registry (2)
Cell line - Methylation microarray (1)
Translation profiling (1)
Cell line - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
Ribo-seq (1)

Release Date

2025 (180)
2023 (158)
2022 (150)
2021 (140)
2024 (132)
2020 (122)
2013 (111)
2015 (99)
2016 (93)
2014 (93)
2019 (82)
2012 (80)
2010 (75)
2011 (72)
2018 (69)
2017 (60)
2008 (28)
2009 (23)
2026 (22)
2005 (7)
2007 (6)
2006 (2)
2002 (1)

Lab affiliation

Abbvie Bioresearch Center (2)
CRUK -CRUK Scotland nstitute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (2)
Functional Proteomics, ICR (2)
Johns Hopkins University (2)
University at buffalo, SUNY (2)
Acting Head of Proteomics (1)
Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Science, University of Utrecht, Padualaan 8, Utrecht, 3584 CH, The Netherlands (1)
Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Old Road, University of Oxford, Oxford OX3 7LD, UK (1)
Bowel Cancer and biomarker laboratory (1)
CRUK -CRUK Scotland Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Cancer & Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ  Integrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA  (lab head) (1)
Cancer Research UK Manchester Institute Systems Oncology (1)
Center for Advanced Biomolecular Recognition, Biomedical Research Institute, Korea Institute of Science and Technology (1)
Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology (1)
Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, CH-8093, Switzerland ( lab head ) (1)
Department of Biotechnology St Aloysius (Deemed to be University) Mangalore – 575 003, Karnataka, India. (1)
Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K. (1)
Department of Pathology, Institute of Systems Biomedicine, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China (1)
Department of Pharmaceutical Sciences, University at Buffalo (SUNY), NY, USA (1)
Department of Pharmaceutical Sciences, University at Buffalo, NY, USA (1)
Experimental Systems Immunology Laboratory, Max Planck Institute of Biochemistry, Martinsried, Germany Institute of Innate Immunity, Department of Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Germany (1)
Experimental Systems Immunology Laboratory, Max Planck Institute of Biochemistry, Martinsried, Germany Institute of Innate Immunity, Department of Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Germany (lab head) (1)
Fondazione Pisana per la Scienza ONLUS (1)
IMM, UTHealth Houston, TX 77030, USA (1)
Knight Cancer Institute Oregon Health & Science University Portland, OR 97239 USA (1)
Kolling institute (1)
Laboratory of Biochemistry, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100 Udine, Italy (1)
Marseille Proteomics, CRCM, IPC, Inserm U1068, CNRS UMR7258, Aix Marseille Université UM105 (1)

Location

United States (13)
China (3)
Japan (3)
Germany (2)
Latvia (1)
Israel (1)
Brazil (1)
Switzerland (1)
France (1)

Keyword

Volatile Organic Compounds (1)
Nano-sensors (1)
Digestive cancers (1)
Pancreatic Cancer Screening (1)
Pancreatic Adenocarcinoma screening (1)
EUS (1)
Endoscopic Ultrasound (1)
Electronic nose (1)
Pancreatic tumor (1)
Esophageal tumor (1)
Thymus tumor (1)
Thyroid Tumor (1)
Thyroid Nodule (1)
Lung Tumor (1)
Circulating tumor cells (CTCs) (1)
Disseminated tumor cells (DTCs) (1)
Magnetic Resonance Imaging (1)
Circulating tumor DNA (ctDNA) (1)
Database (1)
Squamous cell carcinoma of the head and neck (1)
Multi-cancer early detection (1)
Liquid Biopsy (1)
Methylome (1)
Cell-free DNA (1)
Pancreas (1)
Early detection (1)
Liver cancer (1)
MRI (1)
Stomach cancer (1)
Cancer screening (1)

Previous page
1 / 207
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 207
Next page

Sort by:

Relevance

Page size

Emerging mechanisms and promising approaches in pancreatic cancer metabolism.

Pancreatic cancer is an aggressive cancer with a poor prognosis. Metabolic abnormalities are one of the hallmarks of pancreatic cancer, and pancreatic cancer cells can adapt to biosynthesis, energy intake and redox needs through metabolic reprogramming to tolerate nutrient deficiency and hypoxic ...

2025-03-26 | MTBLS12204 | MetaboLights

Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer

BACKGROUND Increasing evidence implicates microbiome involvement in the development and progression of pancreatic ductal adenocarcinoma (PDAC). Studies suggest that reflux of gut or oral microbiota can lead to colonization in the pancreas, resulting in dysbiosis that culminates ...

2023-08-09 | MTBLS7260 | MetaboLights

Multiple Salivary Biomarkers for Early Detection of Pancreatic Cancer

Pancreatic cancer is the fourth leading cause of cancer death. Lack of early detection technology for pancreatic cancer invariably leads to a typical clinical presentation of incurable disease at initial diagnosis. Oral fluid (saliva) meets the demand for non-invasive, accessible, and highly efficie...

ORGANISM(S): Homo sapiens

2008-12-30 | E-GEOD-14245 | biostudies-arrayexpress

Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors

Nutrient-deprived conditions in the tumor microenvironment (TME) restrain cancer cell viability due to increased free radicals and reduced energy production. In pancreatic cancer cells, a cytosolic metabolic enzyme, wild-type isocitrate dehydrogenase 1 (wtIDH1), enables the adaptation to these co...

2022-04-29 | MTBLS4722 | MetaboLights

Metabolome profiling on resectable pancreatic ductal adenocarcinoma patients with early liver metastasis

Pancreatic ductal adenocarcinoma (PDAC) remains difficult to cure because many patients develop liver metastasis even after apparently curative resection. Bile is in close contact with the pancreatobiliary system, but its multi-omic features in resectable PDAC and their relationship to postoperative...

2026-10-17 | MTBLS15948 | MetaboLights

Geographic variation of mutagenic exposures in kidney cancer genomes

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not been identified by conventional epidemiology yet potentially make a substantial contribution to cancer burden1. This pertains to clear cell renal cell carcinoma (ccRCC), fo...

2024-03-26 | MTBLS9394 | MetaboLights

Pancreatic cancer biomarkers in mouse saliva

This is a pilot study. We are trying to detect potential salivary biomarkers in mice with a pancreatic tumor. Global gene expression profiling has shown great promise in high-throughput biomarker discovery for early disease detection in body fluids such as saliva, which is accessible, cost-effectiv...

ORGANISM(S): Mus musculus

2013-06-12 | E-GEOD-47811 | biostudies-arrayexpress

Blood biomarker for pancreatic cancer detection

We analyzed blood samples to identify blood biomarker for pancreatic cancer detection.

ORGANISM(S): Homo sapiens (Human)

2026-06-15 | PXD068790 | Pride

Pancreatic Cancer 1

This is the experiment set used for a paper written in collaboration with Hopkins. It compares genes that are differentially expressed between normal pancreas, pancreatic cell lines and pancreatic adenocarcinoma. Pancreatic cancer is the fifth leading cause of cancer death in the United States. We u...

ORGANISM(S): Homo sapiens

2005-11-23 | E-GEOD-3654 | biostudies-arrayexpress

Expression Data from 22 human pancreatic cancer cell lines grown in triplicates +/- MEK inhibitor CI-1040

Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity. We used microarrays to find gene expression patterns associated with drug response and also identified genes regulated by the MAP kinase pathway 22 pancreatic cell l...

ORGANISM(S): Homo sapiens

2013-04-04 | E-GEOD-45757 | biostudies-arrayexpress

Previous page
1 / 207
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 207
Next page

Sort by:

Relevance

Page size

2067 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

BACKGROUND Increasing evidence implicates microbiome involvement in the development and progression of pancreatic ductal adenocarcinoma (PDAC). Studies suggest that reflux of gut or oral microbiota can lead to colonization in the pancreas, resulting in dysbiosis that culminates ...

OmicsDI is part of the ELIXIR infrastructure

Tweets